Our results demonstrated that a combination of the serum 6-miRNA signature with f(Hb) show good discriminative capacity for detecting patients harbouring AA or CRC, higher than the one exhibited only considering f(Hb) alone. The gene discussed is GSTM1; the disease is colorectal carcinoma.